Top five models for immuno-oncology studies

Scientists at Labcorp have run close to 3,500 preclinical immuno-oncology studies over the past ?ve years. While new models continue to be developed, our scientists have found the following to be their commonly used "workhorse" models, time-tested and optimized for evaluating a wide range of therapeutic approaches. These diverse models offer several histotypes for test agent development, with Labcorp offering the range of capabilities needed to support them.